Skip Nav Destination
Article navigation
Correspondence|
June 1994
Digoxinlike Immunoreactive Substance in Critically III Patients
Institut für Klinische Chemie und Laboratoriumsmedizin und Institut für Arterioskleroseforschung
Institut für Klinische Chemie und Laboratoriumsmedizin und Institut für Arterioskleroseforschung
Westfälische Wilhelms-Universtität Münster Albert-Schweitzer-Straße 33 48149 Münster, Germany
Anesthesiology June 1994, Vol. 80, 1408–1409.
Citation
E. Berendes, M. Walter, Th. Prien, G. Assmann, P. Lawin; Digoxinlike Immunoreactive Substance in Critically III Patients. Anesthesiology 1994; 80:1408–1409 doi: https://doi.org/10.1097/00000542-199406000-00041
Download citation file:
Citing articles via
Most Viewed
Related Articles
Regulation of Peripheral Clock to Oscillation of Substance P Contributes to Circadian Inflammatory Pain
Anesthesiology (July 2012)
Regulation of Spinal Substance P Release by Intrathecal Calcium Channel Blockade
Anesthesiology (July 2011)
Effects of General Anesthetics on Substance P Release and c-Fos Expression in the Spinal Dorsal Horn
Anesthesiology (August 2013)
Effect of Methylprednisolone on Neuropathic Pain and Spinal Glial Activation in Rats
Anesthesiology (May 2004)
Intrathecal Substance P-Saporin in the Dog: Distribution, Safety, and Spinal Neurokinin-1 Receptor Ablation
Anesthesiology (November 2013)